Is NNNN or QCLS more undervalued in 2026?

CirclFi compares Anbio Biotechnology (NNNN) and Q/C Technologies, Inc. (QCLS) using 13 institutional-grade valuation models. NNNN has a Quality of Company score of 2.0/10 while QCLS scores 4.0/10.

Which is a better buy — NNNN or QCLS?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do NNNN and QCLS valuations compare?

NNNN at $34.41 and QCLS at $4.37 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

NNNN vs QCLS Valuation Comparison 2026 — Intrinsic Value Analysis

NNNN

In Vitro & In Vivo Diagnostic Substances

Anbio Biotechnology

Quality

2.0

out of 10

Value Trap

SAFE

Price

$34.41

Last close

Models

13/13

Active

QCLS

In Vitro & In Vivo Diagnostic Substances

Q/C Technologies, Inc.

Quality

4.0

out of 10

Value Trap

LOW

Price

$4.37

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	NNNN Fair Value	NNNN Upside	QCLS Fair Value	QCLS Upside
Bayesian DCF	Intrinsic	$6.12	-82.2%	$1.21	-72.3%
Earnings Power Value	Intrinsic	$1.40	-95.2%	—	—
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$0.34	-99.0%	$0.11	-97.5%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for NNNN vs QCLS — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

NNNN vs QCLS — Which Stock Is More Undervalued?

QCLS scores higher with a 4.0/10 quality rating vs NNNN's 2.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Anbio Biotechnology (NNNN) and Q/C Technologies, Inc. (QCLS) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

NNNN currently trades at $34.41 with a QOC of 2.0/10, while QCLS trades at $4.37 with a QOC of 4.0/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).